|
|
|
|
|
Andrew K.H. Robertson, Andrew Lobbezoo, Louis Moskven, Paul Schaffer and Cornelia Hoehr
With recent impressive clinical results of targeted alpha therapy using 225Ac, significant effort has been directed towards providing a reliable and sufficient supply of 225Ac to enable widespread using of 225Ac-radiopharmaceuticals. TRIUMF has begun pro...
ver más
|
|
|
|
|